Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Clinical trial NCT00329719 · COMPLETED

Trial details

NCT number: NCT00329719
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Neoplasm

Start date: 2006-03-24
Primary completion: 2013-02-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.